Evidence map›Paper›PMID 25379106›Full record

ArticleBiomicrofluidics2014

Simplified prototyping of perfusable polystyrene microfluidics.

Reginald Tran, Byungwook Ahn, David R Myers, Yongzhi Qiu, Yumiko Sakurai, Robert Moot, Emma Mihevc, H Trent Spencer, Christopher Doering, Wilbur A Lam

Open access · bronzeAbstract read
In one paragraph

Article in Biomicrofluidics, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Reginald Tran
Byungwook Ahn
David R Myers
Yongzhi Qiu
Yumiko Sakurai
Robert MootGraduate Program in Molecular and Systems Pharmacology, Laney Graduate School, Emory University, Atlanta , Georgia 30322, USA.
Emma MihevcThe Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta , Georgia 30332, USA.
H Trent Spencer
Christopher Doering
Wilbur A Lam
Emory University · USCenter for Cancer and Blood Disorders · USGeorgia Institute of Technology · USThe Wallace H. Coulter Department of Biomedical Engineering · USWinship Cancer Institute

Funding

Nanomedicine Center for Nucleoprotein MachinesPN2EY018244 · NEI · RICE UNIVERSITY · PI BAO, GANG · 2006 to 2015
$24.4M
Endothelialized microfluidics for sickle cell disease research & drug discoveryR01HL121264 · NHLBI · EMORY UNIVERSITY · PI LAM, WILBUR A · 2014 to 2018
$2.0M
Nanomechanical effects of aldosterone on vaso-occulation in sickle cell diseaseK08HL093360 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI LAM, WILBUR A · 2009 to 2013
$642k
NEI NIH HHS PN2 EY018244NHLBI NIH HHS K08 HL093360NHLBI NIH HHS R01 HL121264
6 · The paper itself

Abstract

Cell culture in microfluidic systems has primarily been conducted in devices comprised of polydimethylsiloxane (PDMS) or other elastomers. As polystyrene (PS) is the most characterized and commonly used substrate material for cell culture, microfluidic cell culture would ideally be conducted in PS-based microsystems that also enable tight control of perfusion and hydrodynamic conditions, which are especially important for culture of vascular cell types. Here, we report a simple method to prototype perfusable PS microfluidics for endothelial cell culture under flow that can be fabricated using standard lithography and wet laboratory equipment to enable stable perfusion at shear stresses up to 300 dyn/cm(2) and pumping pressures up to 26 kPa for at least 100 h. This technique can also be extended to fabricate perfusable hybrid PS-PDMS microfluidics of which one application is for increased efficiency of viral transduction in non-adherent suspension cells by leveraging the high surface area to volume ratio of microfluidics and adhesion molecules that are optimized for PS substrates. These biologically compatible microfluidic devices can be made more accessible to biological-based laboratories through the outsourcing of lithography to various available microfluidic foundries.

Identifiers

PMID25379106
PMCPMC4189295
OpenAlexW1994148935

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.